C-014
Human Patient-Derived Colorectal Cancer Organoid – Transverse Colon
Human Patient-Derived Colorectal Cancer Organoid – Transverse Colon is a 3D in vitro tumor model derived from the transverse colon tissue of a colorectal cancer patient. It preserves the genetic mutations, histological features, and microenvironmental characteristics of the original tumor, including site-specific attributes of mid-colon malignancies. This organoid supports long-term culture while maintaining tumor heterogeneity and growth dynamics. It serves as a biologically relevant model for studying colorectal cancer originating in the transverse colon and its response to therapeutic interventions.
Specifications
- cat no
- C-014
- disease
- Cancer
- organism
- Human
- tissue
- Colon
- growth properties
- Embedded 3D Culture
- biosafety level
- 1
- growth conditions
- 37℃, 95% Air, 5% CO 2
- size quantity
- 1
- product format
- Frozen
- shipping info
- Dry Ice
- storage conditions
- Liquid Nitrogen
- quality control
- All test negative for mycoplasma, bacteria, yeast, and fungi.
- application
- For research use only. Human Patient-Derived Colorectal Cancer Organoid – Transverse Colon is ideal for testing anti-cancer drugs in the context of transverse colon-specific tumor biology. It supports biomarker discovery, functional genetic screening, and validation of personalized treatment regimens. Its site-specific origin enables researchers to explore regional differences in tumor behavior, drug sensitivity, and progression mechanisms. This model is valuable for preclinical screening and precision medicine strategies aimed at improving outcomes in colorectal cancer patients.